BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33632774)

  • 1. Bacterial-Driven Inflammation and Mutant
    DeStefano Shields CE; White JR; Chung L; Wenzel A; Hicks JL; Tam AJ; Chan JL; Dejea CM; Fan H; Michel J; Maiuri AR; Sriramkumar S; Podicheti R; Rusch DB; Wang H; De Marzo AM; Besharati S; Anders RA; Baylin SB; O'Hagan HM; Housseau F; Sears CL
    Cancer Discov; 2021 Jul; 11(7):1792-1807. PubMed ID: 33632774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis.
    Geis AL; Fan H; Wu X; Wu S; Huso DL; Wolfe JL; Sears CL; Pardoll DM; Housseau F
    Cancer Discov; 2015 Oct; 5(10):1098-109. PubMed ID: 26201900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Profiling Reveals the Impact of Genetic Alterations on the Differentiation of Inflammation-Induced Murine Colon Tumors.
    Ghobashi AH; Lanzloth R; Ladaika CA; Masood A; O'Hagan HM
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis.
    Thiele Orberg E; Fan H; Tam AJ; Dejea CM; Destefano Shields CE; Wu S; Chung L; Finard BB; Wu X; Fathi P; Ganguly S; Fu J; Pardoll DM; Sears CL; Housseau F
    Mucosal Immunol; 2017 Mar; 10(2):421-433. PubMed ID: 27301879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell profiling reveals the impact of genetic alterations on the differentiation of inflammation-induced colon tumors.
    Ghobashi AH; Lanzloth R; Ladaika CA; O'Hagan HM
    bioRxiv; 2023 Dec; ():. PubMed ID: 38077052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF
    Reischmann N; Andrieux G; Griffin R; Reinheckel T; Boerries M; Brummer T
    Oncogene; 2020 Sep; 39(38):6053-6070. PubMed ID: 32792685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon Tumors in Enterotoxigenic Bacteroides fragilis (ETBF)-Colonized Mice Do Not Display a Unique Mutational Signature but Instead Possess Host-Dependent Alterations in the APC Gene.
    Allen J; Rosendahl Huber A; Pleguezuelos-Manzano C; Puschhof J; Wu S; Wu X; Boot C; Saftien A; O'Hagan HM; Wang H; van Boxtel R; Clevers H; Sears CL
    Microbiol Spectr; 2022 Jun; 10(3):e0105522. PubMed ID: 35587635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of Murine Colon Tumorigenesis Driven by Enterotoxigenic Bacteroides fragilis Using Cefoxitin Treatment.
    DeStefano Shields CE; Van Meerbeke SW; Housseau F; Wang H; Huso DL; Casero RA; O'Hagan HM; Sears CL
    J Infect Dis; 2016 Jul; 214(1):122-9. PubMed ID: 26908749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.
    Hinoue T; Weisenberger DJ; Pan F; Campan M; Kim M; Young J; Whitehall VL; Leggett BA; Laird PW
    PLoS One; 2009 Dec; 4(12):e8357. PubMed ID: 20027224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer.
    Kochi M; Hinoi T; Niitsu H; Miguchi M; Saito Y; Sada H; Sentani K; Sakamoto N; Oue N; Tashiro H; Sotomaru Y; Yasui W; Ohdan H
    Cancer Sci; 2020 Oct; 111(10):3540-3549. PubMed ID: 32629543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer.
    Ozeki H; Shimada Y; Nakano M; Kondo S; Ohashi R; Miwa Y; Yamai D; Matsumoto A; Abe K; Tajima Y; Ichikawa H; Sakata J; Takii Y; Sugai M; Nagai T; Ling Y; Okuda S; Wakai T
    Hum Pathol; 2024 Mar; 145():71-79. PubMed ID: 38423222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways.
    Noreen F; Küng T; Tornillo L; Parker H; Silva M; Weis S; Marra G; Rad R; Truninger K; Schär P
    Clin Epigenetics; 2019 Dec; 11(1):196. PubMed ID: 31842975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
    Minoo P; Moyer MP; Jass JR
    J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients.
    Naghibalhossaini F; Hosseini HM; Mokarram P; Zamani M
    Pathol Oncol Res; 2011 Dec; 17(4):819-25. PubMed ID: 21455633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF
    Sakamoto N; Feng Y; Stolfi C; Kurosu Y; Green M; Lin J; Green ME; Sentani K; Yasui W; McMahon M; Hardiman KM; Spence JR; Horita N; Greenson JK; Kuick R; Cho KR; Fearon ER
    Elife; 2017 Jan; 6():. PubMed ID: 28072391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis.
    Tong K; Kothari OA; Haro KS; Panda A; Bandari MM; Carrick JN; Hur JJ; Zhang L; Chan CS; Xing J; Gatza ML; Ganesan S; Verzi MP
    Oncogene; 2021 Oct; 40(41):6034-6048. PubMed ID: 34453124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
    Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Salt Administration Decreases Enterotoxigenic
    Hwang S; Yi HC; Hwang S; Jo M; Rhee KJ
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.